Prevention and control of thalassemia in Ramathibodi Hospital, Thailand

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 31, Issue 3, 2000, Pages 561-565

  Jaovisidha, Adithep ^a   Ajjimarkorn, Sauwakon ^a   Panburana, Panyu ^a   Somboonsub, Oraphan ^a   Herabutya, Yongyoth ^a   Rungsiprakarn, Rasig ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIAGNOSTIC TEST; FEMALE; HETEROZYGOTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOZYGOTE; HOSPITAL; HUMAN; PREGNANCY; PRENATAL DIAGNOSIS; RISK FACTOR; THAILAND; THALASSEMIA;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HOSPITALS, URBAN; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; RISK FACTORS; THAILAND; THALASSEMIA;

EID: 0034278863     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. American College of Obstetricians and Gynecologists. (ACOG). Hemoglobinopathies in pregnancy. ACOG technical bulletin. Int J Gynecol Obstet 1996; 53: 184-94.
2. Anandakumar C, Annapoorna V, Chee WY, Chia D, Bongso A, Ratnam SS. Fetal blood sampling and its complications related to the indications for fetal blood sampling. Aust NZ J Obstet Gynaecol 1993; 33: 259-61.
3. Bens P, Darbellay R, Extermann P. Prevention of β-thalassemia major and Hb Bart's hydrops fetalis syndrome. Semin Hematol 1995; 32: 244-61.
4. Cao A, Rosatelli MC. Screening and prenatal diagnosis of the haemoglobinopathies. Bailliere's Clin Haematol 1993; 6: 263-86.
5. Flatz SD, Flatz G. Population screening for β-thalassemia. Lancet 1980; i: 495-6.
6. Fucharoen S, Winichagoon P, Thonglairoam V, et al. Prenatal diagnosis of thalassemia and hemoglobinopathies in Thailand : experience from 100 pregnancies. Southeast Asian J Trop Med Public Health 1991; 22: 16-29.
7. Gehlbach DL, Morgenstern LL. Antenatal screening for thalassemia minor. Obstet Gynecol 1988; 71 : 801-3.
8. Ghosh A, Tang MHY, Liang ST, Ma HK. Ultrasound evaluation of pregnancies at risk for homozygous α-thalassemia-1. Prenat Diagm 1987; 7: 307-13.
9. Ko TM, Tseng LH, Hsu PM, Hwa HL, Lee Ty, Chuang SM. Ultrasonographic scanning of placental thickness and the prenatal diagnosis of homozygous α-thalassemia 1 in the second trimester. Prenat Diagn 1995; 15: 7-10.
10. Lan YH, Ghosh A, Tang MHY, Lee CH, Sin SY. Early ultrasound prediction of pregnancies affected by homozygous α-thalassemia-1. Prenat Diagn 1997; 17: 327-32.
11. Maiavacca R, Tedeschi S, Mosca A, et al. Nonradioactive quantification of low concentrations of hemoglobin A by HPLC for mid trimester prenatal diagnosis of β-thalassemia. Clin Chem 1992; 38: 1906-8.
12. O-prasertsawat P, Suthutvoravut S. Chaturachinda K. Hydrops fetalis due to Bart hemoglobinopathy at Ramathibodi Hospital (1978-1987): A 10-year review. J Med Assoc Thai 1990; 73: 65-8.
13. th International Conference on Thalassemia and the Haemoglobinopathies 1999:78-80.
14. The Thalassemia Working Party of the BCSH General Haematology Task Force. Guidelines for investigation of the α and β-thalassemia traits. J Clin Pathol 1994; 47: 289-95.
15. Yeo GS, Tan KH, Liu TC. Screening for beta thalassemia and HbE traits with the mean red cell volume in pregnant women. Ann Acad Med Singapore 1994; 23: 363-6.